Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Halda Therapeutics Logo
Halda Therapeutics Growth Score
67
CB Rank
9095
Heat Score
52
Halda Therapeutics is a research-stage drug discovery company.
Acquired by
Johnson & Johnson Logo
Johnson & Johnson
Founded
obfuscation
PrivateSeries B New Haven, Connecticut, United States11-50 haldatx.com
Biotechnology
Medical
Therapeutics
Overview

Halda Therapeutics
Total Funding
obfuscation
Growth Score
67
Heat Score
52

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score67
-7 pts
in past quarter
Heat Score 52
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Halda Therapeutics

CB Rank
9095
Halda Therapeutics is a research-stage drug discovery company.
Acquired by
Johnson & Johnson Logo
Johnson & Johnson
Founded
obfuscation
PrivateSeries B New Haven, Connecticut, United States11-50 haldatx.com
Biotechnology
Medical
Therapeutics

Funding Rounds

Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name HALDA THERAPEUTICS INC.
Operating Status Active
Company Type For Profit
Founders  Craig M. Crews
About the Company
Halda Therapeutics is a research-stage drug discovery company, seeking to create the next generation of precision medicine based on a novel therapeutic modality which may be a platform for a number of disease states.
Phone Number 475-210-0212
Contact Email info@haldathera.com
Predictions & Insights

Growth Insight

See this Growth Insight
Halda Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Awards

Products & Services

RIPTAC Therapeutics
A novel class of bifunctional small molecule cancer therapies that selectively kill cancer cells by holding together a tumor-specific protein and an essential cellular protein to disrupt cell function.
HLD-0915
An oral RIPTAC therapeutic candidate targeting metastatic castration-resistant prostate cancer by linking androgen receptor and an essential protein to induce selective cancer cell death.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B
obfuscation
Series B - Halda Therapeutics Logo
Series B - Halda Therapeutics
10
obfuscation
— Series B

Investors

M&A Details

Halda Therapeutics was acquired by Johnson & Johnson for
obfuscation
on
obfuscation
. This deal was done in Cash.
Transaction Name 
Halda Therapeutics acquired by Johnson & Johnson Logo
Halda Therapeutics acquired by Johnson & Johnson
Acquired by 
Johnson & Johnson Logo
Johnson & Johnson
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Board Members and Advisors 1 Contacts 25

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,631
470.91%
 in past month

IT Spend

$1.1MThis year, Halda Therapeutics is projected to spend $1.1M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Email Verification Logo
Email Verification
84
Fierce Pharma Logo
Fierce Pharma
83
Signant Health Logo
Signant Health
80

Active Website Tech Count

23Halda Therapeutics is actively using 23 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Google Tag Manager.
Sub-Organizations
Frequently Asked Questions

Where is Halda Therapeutics's headquarters? Halda Therapeutics is located in New Haven, Connecticut, United States.Who invested in Halda Therapeutics? Halda Therapeutics has 12 investors including Canaan Partners and  Deep Track Capital.When was the last funding round for Halda Therapeutics? Halda Therapeutics closed its last funding round on
obfuscation
from a Series B round.Who are Halda Therapeutics's competitors? Alternatives and possible competitors to Halda Therapeutics may include Tango Therapeutics, Avenzo Therapeutics, and  Iambic.How much funding has Halda Therapeutics raised to date? Halda Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|